Chuck Royce's NAGE Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 12,169 shares of Niagen Bioscience, Inc. (NAGE) worth $38,819, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in NAGE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Niagen Bioscience (NAGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Niagen Bioscience (NAGE) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +12,169 | New Buy | 12,169 | $3.19 |
Chuck Royce's Niagen Bioscience Investment FAQs
Chuck Royce first purchased Niagen Bioscience, Inc. (NAGE) in Q2 2026, acquiring 12,169 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Niagen Bioscience, Inc. (NAGE) for 1 quarters since Q2 2026.
Chuck Royce's largest addition to Niagen Bioscience, Inc. (NAGE) was in Q2 2026, adding 12,169 shares worth $38,819.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 12,169 shares of Niagen Bioscience, Inc. (NAGE), valued at approximately $38,819.
As of the Q2 2026 filing, Niagen Bioscience, Inc. (NAGE) represents approximately 0.00% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Niagen Bioscience, Inc. (NAGE) was 12,169 shares, as reported at the end of Q2 2026.